Clinical Trial Update: People Presenting With Neurocysticercosis in North America

View source ↗

Summary

The NIAID-sponsored clinical trial investigating neurocysticercosis in North America has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurocysticercosis

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Neurocysticercosis | Status: TERMINATED